New indication expands use of BRILINTA beyond cardio-vascular disease to patients with mild-to-moderate stroke November 6, 2020 AstraZenecas BRILINTA(ticagrelor) has been approved in the U.S. to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic stroke (National Institutes of Health Stroke Scale score 5) or high-risk transient ischemic attack (TIA) Continue reading →

The demand within the global heart-lung machines market is expected to rise at a visible pace in the years to follow. The rising incidence of cardiovascular diseases has created new avenues for growth within the global heart-lung machines market. The unprecedented use of heart monitoring devices across the healthcare industry has become a key dynamic of market growth. Continue reading →

Awaiting the answer In the last election a TV show host, billionaire, businessman, perfect gentleman, or a con-man carnival barker was elected. Whatever he was, you had the opportunity to see what he did for this country. Continue reading →

One of the most troubling things we encounter in the health care system in Jamaica is the concept of waiting list. Many patients in need of life-saving care are sometimes put on a waiting list' especially in the public system. While this system appears normalised, it is sub-optimal for many critical conditions especially for patients with heart disease. Continue reading →

The Daily Pennsylvanian is a student-run nonprofit. Please support us by disabling your ad blocker on our site. A recent study from Penn Medicine has found that treating lung cancer patients with proton therapy may help reduce the risk of radiation-induced heart diseases Continue reading →

Cardiac surgery is performed by heart surgeons due to complications in the heart or heart diseases like correct congenital heart disease, valvular heart disease, ischemic heart disease. Typically, neurological damage is the major concerned while doing the cardiac surgery. Patients who are at risk, stroke is higher and occurs generally 2-3% of people having cardiac surgery Continue reading →

Percutaneous transluminal coronary angioplasty (PTCA) refers to a minimally-invasive procedure for opening blocked or narrowed coronary arteries caused by coronary arteries disease (CAD). PTCA balloon catheters help to allow the blood to flow from the arteries to the heart muscles without the need for open heart surgery. Coronary heart disease is caused by smoking, high blood pressure, diabetes, and a high level of cholesterol in the blood. Continue reading →